V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160013455 | 160006544 | 1.78 | 111.8 | Palliative (P) | 2020-05-22 | 2020-05-22 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101498995 |
| 160013457 | 160006545 | 1.66 | 72 | null | 2017-04-05 | 2017-04-12 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100768144 |
| 160013460 | 160006546 | null | 53.3 | Palliative (P) | 2017-09-04 | 2017-09-05 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100364850 |
| 160013461 | 160006547 | 1.7 | 88.4 | Palliative (P) | 2017-12-26 | 2018-01-17 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | RITUXIMAB | 101452805 |
| 160013463 | 160006548 | 0 | 7.7 | Palliative (P) | 2018-02-22 | 2018-02-22 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | TRIAL UNSPECIFIED | 101114092 |
| 160013465 | 160006549 | 1.78 | 84.8 | Palliative (P) | 2019-11-02 | 2019-11-16 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101503806 |
| 160013467 | 160006550 | 1.68 | 64.3 | null | 2019-12-29 | 2020-01-20 | EW EuroEwing 99 : VIDE | 02 | N | TRIAL UNSPECIFIED | 100456432 |
| 160013468 | 160006551 | 1.7 | 63 | Palliative (P) | 2017-02-10 | 2017-02-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101301272 |
| 160013471 | 160006552 | 1.73 | 67 | Palliative (P) | 2017-12-24 | 2018-01-06 | Trial Unspecified | 02 | N | PEMETREXED | 101145327 |
| 160013472 | 160006553 | 1.62 | 76.9 | Palliative (P) | 2021-11-19 | 2021-11-21 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 101351770 |
| 160013476 | 160006555 | 1.63 | 51.8 | Palliative (P) | 2018-09-07 | 2018-09-11 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + DOXORUBICIN | 100993941 |
| 160013477 | 160006556 | 1.78 | 77 | Palliative (P) | 2018-09-13 | 2018-09-13 | Trial Unspecified | 02 | null | TRIAL | 100846649 |
| 160013480 | 160006557 | 1.77 | 89.6 | Palliative (P) | 2016-10-24 | 2016-11-01 | Cisplatin + Pemetrexed | 02 | Y | CISPLATIN + PEMETREXED | 100404107 |
| 160013482 | 160006558 | 1.71 | 61.4 | Palliative (P) | 2017-09-15 | 2017-09-17 | Doxorubicin + Olaratumab | 02 | N | TRIAL UNSPECIFIED | 101091689 |
| 160013483 | 160006559 | 1.68 | 12 | Palliative (P) | 2016-01-21 | 2016-01-27 | Cisplatin + Pemetrexed | 2 | null | CISPLATIN + PEMETREXED | 101422530 |
| 160013484 | 160006560 | 1.6 | 63.5 | Palliative (P) | 2020-12-30 | 2021-01-07 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100543723 |
| 160013489 | 160006561 | 1.63 | 52.5 | Palliative (P) | 2017-12-02 | 2017-12-11 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100695472 |
| 160013490 | 160006562 | 1.72 | 93.4 | Neo-adjuvant (N) | 2018-09-11 | 2018-09-11 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100634336 |
| 160013494 | 160006563 | 1.71 | 74.1 | Palliative (P) | 2020-10-30 | 2020-10-30 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101120069 |
| 160013495 | 160006564 | 1.58 | 54.3 | Palliative (P) | 2018-09-02 | 2018-09-20 | DOXORUBICIN | N | N | DOXORUBICIN | 101848588 |
| 160013498 | 160006565 | 1.51 | 64.2 | Curative (C) | null | 2016-05-21 | Liposomal Doxorubicin 40mg/m2 | null | N | BEVACIZUMAB + CARBO + PACLITAXEL | 101547490 |
| 160013505 | 160006568 | 1.14 | 90.2 | Palliative (P) | 2016-09-20 | 2016-10-11 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100753935 |
| 160013507 | 160006569 | 0 | 10 | Palliative (P) | null | 2019-06-29 | Dasatinib | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100359082 |
| 160013509 | 160006570 | 1.84 | 43.7 | Palliative (P) | 2019-07-25 | 2019-07-26 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101424005 |
| 160013510 | 160006571 | 0 | 8.9 | Curative (C) | 2017-03-10 | 2017-04-01 | Bevacizumab 15mg/kg | 2 | N | TRIAL | 100676438 |
| 160013511 | 160006572 | null | null | Curative (C) | null | 2016-09-20 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 100668475 |
| 160013512 | 160006573 | 1.84 | 82 | Palliative (P) | 2017-10-23 | 2017-10-24 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100500509 |
| 160013515 | 160006574 | 1.78 | 91.2 | Palliative (P) | 2016-04-15 | 2016-05-05 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101427312 |
| 160013516 | 160006575 | 1.79 | 82.2 | Palliative (P) | 2016-11-01 | 2016-11-01 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100157576 |
| 160013518 | 160006576 | 1.7 | 58.1 | Neo-adjuvant (N) | 2018-06-23 | 2018-07-28 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101109799 |
| 160013519 | 160006577 | 1.86 | 75 | Neo-adjuvant (N) | 2016-03-04 | 2016-03-26 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101756989 |
| 160013520 | 160006578 | 1.75 | 68 | Palliative (P) | 2016-11-23 | 2016-12-07 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100810587 |
| 160013522 | 160006579 | 1.75 | 96.6 | Palliative (P) | 2018-06-30 | 2018-07-02 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101062105 |
| 160013523 | 160006580 | 1.66 | 74 | Adjuvant (A) | 2018-09-25 | 2018-10-12 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101098572 |
| 160013528 | 160006581 | 1.75 | 71.3 | Palliative (P) | null | null | Liposomal Doxorubicin 50mg/m2 | 02 | null | PEMETREXED | 100518854 |
| 160013529 | 160006582 | 1.51 | 78 | Palliative (P) | 2017-06-27 | 2017-07-06 | DOXORUBICIN | null | N | TRIAL UNSPECIFIED | 100748779 |
| 160013534 | 160006583 | 1.82 | 77.4 | Curative (C) | 2017-06-27 | 2017-06-27 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 101401548 |
| 160013535 | 160006584 | 1.7 | 58.6 | Palliative (P) | 2017-10-19 | 2017-10-20 | EW EuroEwing 2012 Arm B VDC | N | N | PEMBROLIZUMAB | 100762176 |
| 160013537 | 160006585 | 1.49 | 85 | Palliative (P) | null | 2019-09-02 | Liposomal Doxorubicin (Caelyx) | N | N | CARBOPLATIN + PACLITAXEL | 100680839 |
| 160013538 | 160006586 | 1.5 | 91.3 | 03 | 2018-09-18 | 2018-10-03 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | TRABECTEDIN | 101693406 |
| 160013540 | 160006587 | 1.8 | 91.3 | Neo-adjuvant (N) | 2016-07-27 | 2016-08-10 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100878532 |
| 160013541 | 160006588 | 1.63 | 18.25 | Neo-adjuvant (N) | 2016-06-29 | 2016-06-30 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100322833 |
| 160013544 | 160006589 | 1.68 | 115 | Curative (C) | 2019-01-09 | 2019-01-09 | Carboplatin AUC 2 - 5 | 2 | N | CARBOPLATIN | 101062780 |
| 160013548 | 160006590 | 1.67 | 88.9 | Neo-adjuvant (N) | 2016-11-25 | 2016-11-25 | LIPOSOMAL DOXORUBICIN | 02 | N | TRIAL UNSPECIFIED | 101259043 |
| 160013549 | 160006591 | 1.86 | 71.9 | Palliative (P) | 2013-06-12 | 2013-06-28 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100745459 |
| 160013551 | 160006592 | 1.71 | 62 | Palliative (P) | 2016-06-21 | 2016-06-21 | Cisplatin + Doxorubicin | 2 | N | CISPLATIN + ETOPOSIDE | 101123134 |
| 160013553 | 160006593 | 1.83 | 47.6 | Palliative (P) | 2017-07-31 | 2017-08-04 | Doxorubicin + Olaratumab | 02 | N | DACTINOMYCIN + VINCRISTINE | 101516505 |
| 160013554 | 160006594 | 1.55 | 61.8 | Palliative (P) | 2017-06-10 | 2017-06-27 | TEMOZOLOMIDE | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100125814 |
| 160013555 | 160006595 | 1.68 | 95.6 | Curative (C) | 2020-05-08 | 2020-05-21 | Doxorubicin + Ifosfamide | 02 | N | CYCLOPHOSPHAMIDE | 101214688 |
| 160013557 | 160006596 | 1.81 | 60.9 | Neo-adjuvant (N) | 2019-10-17 | 2019-11-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100930769 |